503a retatrutide (LY3437943) Retatrutide Dose Escalation Chart &

Widely used for type 2 diabetes mellitus and obesity, glucagon-like peptide-1 receptor agonists (GLP-1RAs) may increase risk for injection-site reactions, especially exenatide and dulaglutide (Trulicity, Eli Lilly)

Because these medications reduce appetite, its easy to under-consume protein, the very thing your body needs to preserve muscle

Expressing only enough for comfort if breasts feel painfully full

Will research begin to shift toward identifying which patient subgroups benefit most from GLP-1s for weight loss, maximizing the value proposition

The doctor suggested surgery, but I didnt want to leave scars or bear the high cost

The rising expectation for GLP-1 coverage at work Employee expectations around health benefits are changing fast, especially as newer treatment options become more widely discussed and understood